TNXP MEXC RealStocks
Own real TNXP shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 12:26:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.87, with a market capitalization of $79.67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.78 to $20.56. This page covers its latest market performance, valuation, price trends and company information.
$79.67M | |
$3.91 | |
$4.01 | |
$3.78 | |
$3.87 | |
1.67K | |
738.05K | |
-- | |
$20.56 | |
$3.78 | |
-- | |
-- |
Tonix Pharmaceuticals Holding Corp. (TNXP) is trading at $3.87 in pre-market trading as of 2026-11-12 12:22:00, unchanged from the previous close of $3.87
Pre-market trading shows how investors are pricing TNXP before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Over the past seven days, Tonix Pharmaceuticals Holding Corp. (TNXP) moved from $5.19 to $3.87, representing a decline of 25.43% ($1.32).
The stock traded between $3.78 and $5.39 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.21 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.6%
TNXP is currently trading at $3.87, placing it 0.6% of the way from its 52-week low of $3.78 to its 52-week high of $20.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 142 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Tonix Pharmaceuticals Holding Corp.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Tonix Pharmaceuticals Holding Corp. (TNXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TNXP, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TNXP shares and USD.
TNXP Shares to USD
1.00 TNXP shares = 3.87 USD
Calculations are estimates based on the latest available price and are for reference only.